Boehringer Ingelheim's Oramorph SR 10mg, 30mg, 60mg and 100mg tablets (morphine sulphate) will be discontinued from September 1, when stocks are exhausted. The company says that Oramorph oral solution, concentrated oral solution and unit dose vials will continue to be available n Alliance Pharmaceuticals will be discontinuing its 1,000ml bottles of Biorphen liquid (orphenadrine hydrochloride 25mg/5ml) as soon as stocks are exhausted. The company expects this to be during mid-September. The 200ml bottles will continue to be available.